Robotic-Assisted Laparoscopic Surgery Market Report 2024

This Robotic-Assisted Laparoscopic Surgery market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The robotic-assisted laparoscopic surgery market size has grown strongly in recent years. It will grow from $128.38 billion in 2023 to $140.9 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth during the historic period can be attributed to factors such as rising investments in healthcare robotics, increasing global healthcare expenditures, a rise in robotic surgery training programs, growing demand for personalized surgical solutions, and expansion in research and development efforts.

The robotic-assisted laparoscopic surgery market size is expected to see rapid growth in the next few years. It will grow to $207.72 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth anticipated in the forecast period can be attributed to factors such as the rising demand for less invasive surgical procedures, the increasing adoption of automated instruments, a growing prevalence of bone degenerative diseases, a rise in chronic disease cases, and an expanding elderly population. Key trends expected during this period include technological advancements, the integration of artificial intelligence (AI), machine learning, simulation-based training, and the development of microrobotics.

The increasing demand for surgical procedures is projected to drive the growth of the robotic-assisted laparoscopic surgery market in the future. Surgical procedures involve medical interventions that physically alter tissues and organs using manual or instrumental methods. The rising demand for these procedures is attributed to greater awareness of health and cosmetic options, alongside a growing prevalence of chronic and age-related conditions. Robotic-assisted laparoscopic surgery represents a notable advancement in surgical techniques, providing improved precision and control that make complex operations more feasible while reducing patient recovery times and minimizing surgical risks. For example, in August 2023, The Aesthetic Society, a U.S.-based organization focused on plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures in 2022, marking a 2% increase from 2021. As a result, the growing demand for surgical procedures is fueling the expansion of the robotic-assisted laparoscopic surgery market.

Key players in the robotic-assisted laparoscopic surgery market are concentrating on developing advanced technologies, such as AI platforms for robotic surgery, to assist surgeons in reviewing and refining their techniques. These AI platforms integrate sophisticated artificial intelligence with robotic surgical systems to enhance precision, automate certain tasks, and improve decision-making during surgical procedures. The objective is to optimize surgical outcomes by providing surgeons with real-time insights, analyses, and control tools. For instance, in July 2024, Medtronic, a U.S.-based medical device company, introduced the Live Stream function for its Touch Surgery ecosystem of digital technologies. This new feature enables secure live streaming of surgical procedures, creating a virtual learning platform where medical professionals can remotely observe expert techniques, simulating an in-person experience. This technology also enhances post-operative analysis through 14 advanced AI algorithms that generate insights from surgical videos, primarily focused on laparoscopic and robotic-assisted procedures. This development is part of broader efforts to incorporate advanced computing capabilities into operating rooms worldwide to improve surgical training, operational efficiency, and patient outcomes.

In November 2022, CMR Surgical, a UK-based medical device manufacturer, entered into a partnership with Ethicon for an undisclosed amount. This collaboration aims to enhance access to advanced surgical robotics and laparoscopic instruments by integrating CMR's Versius system with Ethicon's complementary surgical technologies in key global markets. Ethicon, a U.S.-based medical device company, specializes in surgical products and technologies, including robotic-assisted laparoscopic surgery.

Major companies operating in the robotic-assisted laparoscopic surgery market are Johnson & Johnson, Medtronic PLC, Doosan Corporation, Intuitive Surgical Inc., Vicarious Surgical Inc., MedStar Health Inc., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Corza Medical, CMR Surgical Ltd., Distalmotion S.A., Titan Medical Inc., Medrobotics Corporation, Asensus Surgical Inc., SS Innovations China Co. Ltd., Moon Surgical Inc., Levita Magnetics, EndoQuest Robotics, FreeHand Surgeon, Shandong Weigao Surgical Robot.

Asia-Pacific was the largest region in the robotic-assisted laparoscopic surgery market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic-assisted laparoscopic surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the robotic-assisted laparoscopic surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Robotic-assisted laparoscopic surgery is a minimally invasive surgical technique that merges laparoscopic surgery with robotic technology. In this method, surgeons utilize a robotic system to maneuver specialized instruments through small incisions in the patient's body, while a high-definition camera provides a magnified view of the surgical site. This approach is employed for various procedures involving the abdomen, pelvis, and thoracic cavity, and is particularly useful for complex surgeries that require enhanced precision.

The primary types of robotic-assisted laparoscopic surgeries include robotic-assisted radical prostatectomy, robotic-assisted partial nephrectomy, robotic-assisted nephrectomy, among others. Robotic-assisted radical prostatectomy is a minimally invasive procedure where robotic systems aid surgeons in the removal of the prostate gland. These surgeries are performed in a range of settings, such as hospitals and ambulatory surgical centers, and cater to diverse end users, including both inpatient and outpatient populations.

The robotic-assisted laparoscopic surgery market research report is one of a series of new reports that provides robotic-assisted laparoscopic surgery market statistics, including robotic-assisted laparoscopic surgery industry global market size, regional shares, competitors with a robotic-assisted laparoscopic surgery market share, detailed robotic-assisted laparoscopic surgery market segments, market trends, and opportunities, and any further data you may need to thrive in the robotic-assisted laparoscopic surgery industry. This robotic-assisted laparoscopic surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The robotic-assisted laparoscopic surgery market includes revenues earned by providing colorectal surgery, and gastric bypass. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.